Annuska M Glas
Annuska M Glas
Verified email at - Homepage
Cited by
Cited by
A gene-expression signature as a predictor of survival in breast cancer
MJ Van De Vijver, YD He, LJ Van't Veer, H Dai, AAM Hart, DW Voskuil, ...
New England Journal of Medicine 347 (25), 1999-2009, 2002
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer
M Buyse, S Loi, L Van't Veer, G Viale, M Delorenzi, AM Glas, ...
Journal of the National Cancer Institute 98 (17), 1183-1192, 2006
70-gene signature as an aid to treatment decisions in early-stage breast cancer
F Cardoso, LJ van’t Veer, J Bogaerts, L Slaets, G Viale, S Delaloge, ...
New England Journal of Medicine 375 (8), 717-729, 2016
Converting a breast cancer microarray signature into a high-throughput diagnostic test
AM Glas, A Floore, LJMJ Delahaye, AT Witteveen, RCF Pover, N Bakx, ...
BMC genomics 7 (1), 1-10, 2006
Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer
R Salazar, P Roepman, G Capella, V Moreno, I Simon, C Dreezen, ...
Journal of clinical oncology 29 (1), 17-24, 2011
Gene expression profiles of primary breast tumors maintained in distant metastases
B Weigelt, AM Glas, LFA Wessels, AT Witteveen, JL Peterse, LJ van't Veer
Proceedings of the National Academy of Sciences 100 (26), 15901-15905, 2003
Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer
B Weigelt, Z Hu, X He, C Livasy, LA Carey, MG Ewend, AM Glas, ...
Cancer research 65 (20), 9155-9158, 2005
The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study
S Mook, MK Schmidt, G Viale, G Pruneri, I Eekhout, A Floore, AM Glas, ...
Breast cancer research and treatment 116 (2), 295-302, 2009
Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER)
JM Bueno-de-Mesquita, WH van Harten, VP Retel, LJ van't Veer, ...
The lancet oncology 8 (12), 1079-1087, 2007
The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer
ME Straver, AM Glas, J Hannemann, J Wesseling, MJ van de Vijver, ...
Breast cancer research and treatment 119 (3), 551-558, 2010
Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment
AM Glas, MJ Kersten, LJMJ Delahaye, AT Witteveen, RE Kibbelaar, ...
Blood 105 (1), 301-307, 2005
Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.
AM Glas, L Knoops, L Delahaye, MJ Kersten, RE Kibbelaar, LA Wessels, ...
Validation of 70-gene prognosis signature in node-negative breast cancer
JM Bueno-de-Mesquita, SC Linn, R Keijzer, J Wesseling, DSA Nuyten, ...
Breast cancer research and treatment 117 (3), 483-495, 2009
Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary
HM Horlings, RK van Laar, JM Kerst, HH Helgason, J Wesseling, ...
Journal of Clinical Oncology 26 (27), 4435-4441, 2008
The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age
S Mook, MK Schmidt, B Weigelt, B Kreike, I Eekhout, MJ Van de Vijver, ...
Annals of oncology 21 (4), 717-722, 2010
Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort
BS Wittner, DC Sgroi, PD Ryan, TJ Bruinsma, AM Glas, A Male, S Dahiya, ...
Clinical Cancer Research 14 (10), 2988-2993, 2008
Independent validation of a prognostic genomic signature (ColoPrint) for patients with stage II colon cancer
M Maak, I Simon, U Nitsche, P Roepman, M Snel, AM Glas, T Schuster, ...
Annals of surgery 257 (6), 1053-1058, 2013
Representation of rearranged VH gene segments in the human adult antibody repertoire.
I Suzuki, L Pfister, A Glas, C Nottenburg, EC Milner
The Journal of Immunology 154 (8), 3902-3911, 1995
The human heavy chain Ig V region gene repertoire is biased at all stages of B cell ontogeny, including early pre-B cells.
P Kraj, SP Rao, AM Glas, RR Hardy, EC Milner, LE Silberstein
The Journal of Immunology 158 (12), 5824-5832, 1997
A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response
O Krijgsman, P Roepman, W Zwart, JS Carroll, S Tian, FA de Snoo, ...
Breast cancer research and treatment 133 (1), 37-47, 2012
The system can't perform the operation now. Try again later.
Articles 1–20